Literature DB >> 9892694

The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival.

K M Dougherty1, J M Pearson, A Y Yang, R J Westrick, M S Baker, D Ginsburg.   

Abstract

Plasminogen activator inhibitor-2 (PAI-2), a member of the serpin gene family, is thought to serve as a primary regulator of plasminogen activation in the extravascular compartment. High levels of PAI-2 are found in keratinocytes, monocytes, and the human trophoblast, the latter suggesting a role in placental maintenance or embryo development. The primarily intracellular distribution of PAI-2 also may indicate a unique regulatory role in a protease-dependent cellular process such as apoptosis. To examine the potential functions of PAI-2 in vivo, we generated PAI-2-deficient mice by gene targeting in embryonic stem cells. Homozygous PAI-2-deficient mice exhibited normal development, survival, and fertility and were also indistinguishable from normal controls in response to a bacterial infectious challenge or endotoxin infusion. No differences in monocyte recruitment into the peritoneum were observed after thioglycollate injection. Epidermal wound healing was equivalent among PAI-2 -/- null and control mice. Finally, crossing PAI-2 -/- with PAI-1 -/- mice to generate animals deficient in both plasminogen activator inhibitors failed to uncover an overlap in function between these two related proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892694      PMCID: PMC15197          DOI: 10.1073/pnas.96.2.686

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation.

Authors:  W P Fay; A D Shapiro; J L Shih; R R Schleef; D Ginsburg
Journal:  N Engl J Med       Date:  1992-12-10       Impact factor: 91.245

2.  Genomic DNA microextraction: a method to screen numerous samples.

Authors:  R Ramírez-Solis; J Rivera-Pérez; J D Wallace; M Wims; H Zheng; A Bradley
Journal:  Anal Biochem       Date:  1992-03       Impact factor: 3.365

3.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene.

Authors:  V L Tybulewicz; C E Crawford; P K Jackson; R T Bronson; R C Mulligan
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

4.  The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity.

Authors:  G von Heijne; P Liljeström; P Mikus; H Andersson; T Ny
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

5.  Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2.

Authors:  S Kumar; C Baglioni
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

6.  Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme.

Authors:  C A Ray; R A Black; S R Kronheim; T A Greenstreet; P R Sleath; G S Salvesen; D J Pickup
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

7.  Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.

Authors:  N Aoki; H Saito; T Kamiya; K Koie; Y Sakata; M Kobakura
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin.

Authors:  R D Ye; S M Ahern; M M Le Beau; R V Lebo; J E Sadler
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

9.  Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.

Authors:  M K Eskandari; G Bolgos; C Miller; D T Nguyen; L E DeForge; D G Remick
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

10.  Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors.

Authors:  E K Kruithof; C Tran-Thang; A Gudinchet; J Hauert; G Nicoloso; C Genton; H Welti; F Bachmann
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

View more
  32 in total

Review 1.  SERPINB2-its regulation and interplay with aryl hydrocarbon receptor.

Authors:  Damian Brauze
Journal:  J Appl Genet       Date:  2021-01-02       Impact factor: 3.240

2.  TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2.

Authors:  Mireille Delhase; Soo-Youl Kim; Ho Lee; Aya Naiki-Ito; Yi Chen; Eu-Ree Ahn; Kazuhiro Murata; Se-Jin Kim; Norman Lautsch; Koichi S Kobayashi; Tomoyuki Shirai; Michael Karin; Makoto Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

3.  Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice.

Authors:  J C Chan; D A Duszczyszyn; F J Castellino; V A Ploplis
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.

Authors:  S A Siefert; C Chabasse; S Mukhopadhyay; M H Hoofnagle; D K Strickland; R Sarkar; T M Antalis
Journal:  J Thromb Haemost       Date:  2014-09-30       Impact factor: 5.824

5.  The Caenorhabditis elegans muscle specific serpin, SRP-3, neutralizes chymotrypsin-like serine peptidases.

Authors:  Stephen C Pak; Christopher Tsu; Cliff J Luke; Yuko S Askew; Gary A Silverman
Journal:  Biochemistry       Date:  2006-04-11       Impact factor: 3.162

6.  Targeted disruption of SPI3/Serpinb6 does not result in developmental or growth defects, leukocyte dysfunction, or susceptibility to stroke.

Authors:  Katrina L Scarff; Kheng S Ung; Harshal Nandurkar; Peter J Crack; Catherina H Bird; Phillip I Bird
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 7.  Wound-healing studies in transgenic and knockout mice.

Authors:  Richard Grose; Sabine Werner
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

8.  Estrogen-induced uterine abnormalities in TIMP-1 deficient mice are associated with elevated plasmin activity and reduced expression of the novel uterine plasmin protease inhibitor serpinb7.

Authors:  Xuan Zhang; Etter Hoang; Warren B Nothnick
Journal:  Mol Reprod Dev       Date:  2009-02       Impact factor: 2.609

9.  Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif.

Authors:  Grant A Darnell; Toni M Antalis; Ricky W Johnstone; Brett W Stringer; Steven M Ogbourne; David Harrich; Andreas Suhrbier
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

10.  An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury.

Authors:  Cliff J Luke; Stephen C Pak; Yuko S Askew; Terra L Naviglia; David J Askew; Shila M Nobar; Anne C Vetica; Olivia S Long; Simon C Watkins; Donna B Stolz; Robert J Barstead; Gary L Moulder; Dieter Brömme; Gary A Silverman
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.